12 Results

People

  1. Giralt
    Giralt
  2. Hassoun
    Hassoun
  3. Koehne
    Koehne
  4. Landau
    Landau
  5. Lesokhin
    Lesokhin
  6. Chung
    Chung
  7. Devlin
    Devlin
  8. Korde
    Korde
  9. Landgren
    Landgren
  10. Lendvai
    Lendvai

Groups

  1. Bone Marrow Transplant (12)
  2. Center for Hematologic Malignancies (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Hematologic Malignancies Research (12)
  6. Hematologic Malignancies, Division of (12)
  7. Myeloma (12)
  8. Survivorship Research (12)
  9. Biostatistics Service (11)
  10. Nursing (3)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Guenther Koehne"
  4. "Neha Korde"
  5. "Meeting abstract"
Formats
  1. Meeting Abstract (12)
Groups
  1. Bone Marrow Transplant (12)
  2. Center for Hematologic Malignancies (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Hematologic Malignancies Research (12)
  6. Hematologic Malignancies, Division of (12)

More Groups

People
  1. Alexander Lesokhin (12)
  2. David Chung (12)
  3. Guenther Koehne (12)
  4. Hani Hassoun (12)
  5. Heather Landau (12)
  6. Neha Korde (12)

More People

Years
  1. 2017 (7)
  2. 2016 (2)
  3. 2015 (3)
Publications
  1. Blood (5)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Clinical Lymphoma, Myeloma and Leukemia (3)
  4. Haematologica (1)
Publishers
  1. Elsevier Inc. (6)
  2. American Society of Hematology (5)
  3. Ferrata Storti Foundation (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depth and timing of improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G. L.; Assal, A.; Hsu, M.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)
    Meeting Abstract

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Chung, D.; Landau, H.; Korde, N.; Mailankody, S.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Giralt, S.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Meeting Abstract

    Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Whole exome sequencing from nine independent sites of extraosseous disease in a single patient with relapsed multiple myeloma show that extramedullary disease arise through a combination of branched and parallel evolution
    Meeting Abstract

    Landau, H.; Fan, J.; Giralt, S. A.; Peled, J. U.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A response adapted approach to induction treatment in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Weltz, J.; Zhou, Q.; Devlin, S. M.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A. M.; Korde, N.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Autologous hematopoietic stem cell transplantation overcomes primary refractory disease in multiple myeloma patients treated with novel agents
    Meeting Abstract

    Shah, G. L.; Hsu, M.; Devlin, S.; Chung, D. J.; Hassoun, H.; Koehne, G.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; more...
    Blood (2015)

    Fulltext@MSK | Save